ars-pharma.com - SPRY Company profit before taxes, interest and amortization
The compact spray format optimizes supply chains, accelerating delivery to pharmacies for ARS Pharmaceuticals (SPRY). Production and packaging are outsourced to external CMO plants, while the presence of insurance reserves mitigates vendor dependency. The developer of Neffy attracts experts through an ambitious corporate culture and RSUs. The trend in pre-tax operating profit demonstrates the stability of the model, with the indicator currently standing at 0.00.
ARS Pharmaceuticals, Inc. (SPRY) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio ARS Pharmaceuticals|SPRY - Long-Term Debt to Capital|Short-Term Debt to Capital ARS Pharmaceuticals Inc|SPRY - Company Debts|Debt to Net Assets Ratio ARS Pharmaceuticals|SPRY - Company Long-Term Debt|Short-Term Debt Volume ARS Pharmaceuticals|Intermediate Coverage Ratio ars-pharma.com
- earnings and market ratios statistics:
SPRY - Company Net Income|Forward Earnings ARS Pharmaceuticals|SPRY - P/E Multiple|Future Price to Earnings Multiple ars-pharma.com|SPRY - PEG Multiple|EV/EBITDA Multiple ARS Pharmaceuticals|SPRY - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year ARS Pharmaceuticals|SPRY - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ars-pharma.com|SPRY - Earnings growth in current year|Earnings growth forecast for next year ARS Pharmaceuticals
Analysis of all company metrics:ARS Corp
Absolute operating profit measures the daily volume of cash generated by the core business before accounting for financial obligations. This metric captures the net result of operating activities by subtracting current expenses from revenue. By analyzing the trend of operating profit before interest and taxes, an investor can see the actual speed of value creation. For ARS Pharmaceuticals (SPRY), the negative trend reflects a phase of active capital burn, driven by the costs of bringing a new drug to market, which temporarily exceed the incoming cash flow.
Competitors of ARS Pharmaceuticals (SPRY)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos)|Operating profit EBITDA ANI Pharmaceuticals Inc ANIP|MNKD - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization AMPH (Amphastar Corp)|Pacira BioSciences (PCRX) - Profit before payment of interest, taxes and amortization|TBPH - Operating income before deduction of amortization|Operating profit before deduction of amortization AQST|SCPH: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tectonic Therapeutic, Inc. (TECX)|TNXP: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|Income before deduction of interest, taxes and amortization EPRX|BioHarvest Sciences Inc. - Operating profit EBITDA|EXOZ - Operating profit EBITDA|oramed.com (ORMP) - Profit before payment of interest, taxes and amortization|Entera Bio - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization MindWalk Holdings|Operating profit before deduction of amortization abvcpharma.com (ABVC)|Operating profit EBITDA CPIX|Operating profit EBITDA Quantum BioPharma Ltd. (QNTM)|Operating profit EBITDA FGEN (FibroGen Corp)|TELO - Operating profit before deduction of amortization|Rani Therapeutics Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Synergy CHC Corp|RLYB (rallybio.com) - Operating profit before deduction of amortization|Lexaria Bioscience Corp. (LEXX) - Operating profit EBITDA|Operating profit before deduction of amortization PULM|PTHL (Pheton) - Company profit before taxes, interest and amortization|Operating profit EBITDA APM|Operating income before deduction of amortization lyratherapeutics.com|Operating profit EBITDA IBO (Impact BioMedical)|TNFA - Operating profit before deduction of amortization|cbdMD Corp - Operating profit EBITDA|PRFX - Operating profit EBITDA|altamiratherapeutics.com (CYTO) - Profit before payment of interest, taxes and amortization|LIPO (lipella.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization OptiNose|Pieris Pharmaceuticals Inc (PIRS) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Procaps Group SA (PROC)|Operating income before deduction of amortization Petros Pharma|Profit before payment of interest, taxes and amortization Qilian International QLI|SLRN (acelyrin.com) - Profit before deduction of interest, taxes, depreciation and amortization|TFFP - Profit before payment of interest, taxes and amortization
